Anticancer Imidazoacridinone C-1311 is Effective in Androgen-Dependent and Androgen-Independent Prostate Cancer Cells.

Niemira, Magdalena; Borowa-Mazgaj, Barbara; Bader, Samuel B; Moszynska, Adrianna; Ratajewski, Marcin; Karas, Kaja; Kwasniewski, Miroslaw; Kretowski, Adam; Mazerska, Zofia; Hammond, Ester M; Skwarska, Anna.

Afiliación

Niemira M; Clinical Research Centre, Medical University of Bialystok, 15-276 Bialystok, Poland.
Borowa-Mazgaj B; Division of Biochemical Toxicology, National Center for Toxicological Research, Jefferson, AR 72079, USA.
Bader SB; Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK.
Moszynska A; Department of Biology and Pharmaceutical Botany, Medical University of Gdansk, 80-416 Gdansk, Poland.
Ratajewski M; Laboratory of Epigenetics, Institute of Medical Biology PAS, 93-232 Lodz, Poland.
Karas K; Laboratory of Epigenetics, Institute of Medical Biology PAS, 93-232 Lodz, Poland.
Kwasniewski M; Centre for Bioinformatics and Data Analysis, Medical University of Bialystok, 15-276 Bialystok, Poland.
Kretowski A; Clinical Research Centre, Medical University of Bialystok, 15-276 Bialystok, Poland.
Mazerska Z; Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, 15-276 Bialystok, Poland.
Hammond EM; Department of Pharmaceutical Technology and Biochemistry, Gdansk University of Technology, 80-233 Gdansk, Poland.
Skwarska A; Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK.